Global Down Syndrome

Summer 2016

Issue link: https://viewer.e-digitaledition.com/i/728625

Contents of this Issue

Navigation

Page 10 of 31

SCIENCE SNPs A GENE ON CHROMOSOME 21 INVOLVED IN BRAIN DEVELOPMENT Researchers have identified a gene on chromosome 21, known as EURL, with potentially important roles in brain function. Scientists demonstrated that the gene is active in the outer layers of the brain, and disrupting this gene impairs cellular proliferation and neuronal function in mice. These results open up the possibility that deregulated activity of this gene in the context of trisomy 21 could contribute to neurological dysfunction in humans. Future studies will be required to explain the gene's mechanism of action and whether it provides opportunities for therapeutic interventions. Scientific Reports, JULY 2016 UNDERSTANDING ALZHEIMER'S DISEASE AS A CONDITION OF THE IMMUNE SYSTEM Although it is well established that excessive accumulation of the beta- amyloid protein into brain plaques is a driver of Alzheimer's disease progression, the normal function of this protein is a matter of debate. Researchers at Massachusetts General Hospital have demonstrated that beta-amyloid protein has antimicrobial properties and can protect against fungal and bacterial infections in several laboratory settings, including a mouse model of Alzheimer's disease. These findings open up the possibility that Alzheimer's disease is caused by an exacerbated immune reaction, whereby a natural immune defense mechanism leads to neurological dysfunction. These results also support the provocative hypothesis that Alzheimer's disease could involve an unidentified pathogen. Future research will be needed to confirm this hypothesis and fully elucidate the immune role of the amyloid protein. Science Translational Medicine, MAY 2016 MOLECULAR UNDERPINNINGS TO PERIPHERAL NERVOUS SYSTEM DYSFUNCTION Using a mouse model of Down syndrome, research at Johns Hopkins University revealed that high levels of RCAN1, a gene that exists on chromosome 21 and may inhibit the complex process of peripheral nervous system development, were linked to neuron loss and impaired nerve growth. Deleting the extra copy of RCAN1 had positive effects on nerve growth and neuron survival. Crnic commentary: These findings pave the way for research that may lead to better understanding of why people with Down syndrome have difficulties regulating blood pressure, cardiac rate, and blood glucose levels, which could illuminate ways to improve their well-being. Nature Communications, DECEMBER 2015 GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Summer 2016